Clinical trials of natural products as chemopreventive agents for prostate cancer

被引：48

作者：

Bemis, Debra L. ^{[1
]}

Katz, Aaron E. ^{[1
]}

Buttyan, Ralph ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, Dept Urol, Coll Phys & Surg, New York, NY 10032 USA

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2006年 / 15卷 / 10期

关键词：

chemoprevention; clinical trials; green tea catechins; isoflavones; lycopene; pomegranate phenolics; prostate cancer; selenium; vitamin D; vitamin E; Zyflamend (R);

D O I：

10.1517/13543784.15.10.1191

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Epidemiological research on prostate cancer risk in men throughout the world has identified significant correlations between dietary habits and prostate cancer occurrence. These studies served as a catalyst for exploration into the potential of dietary substances to act as chemopreventive agents against this disease, and include green tea catechins, lycopene, soy isoflavones, pomegranate phenolics, selenium, vitamins E and D, curcumin and resveratrol. Before these agents (in the dietary or purified forms) can be recommended as useful chemopreventive strategies for patients, their activity must be confirmed in rigorously designed clinical trials. This review discusses the preclinical and clinical data available for these dietary agents and describes relevant clinical trials currently being conducted.

引用

页码：1191 / 1200

页数：10

共 103 条

[11] Zyflamend®, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression [J].

Bemis, DL ;

Capodice, JL ;

Anastasiadis, AG ;

Katz, AE ;

Buttyan, R .

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2005, 52 (02) :202-212

[12] A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo [J].

Bemis, DL ;

Capodice, JL ;

Desai, M ;

Buttyan, R ;

Katz, AE .

CLINICAL CANCER RESEARCH, 2004, 10 (15) :5282-5292

[13] Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study [J].

Bettuzzi, S ;

Brausi, M ;

Rizzi, F ;

Castagnetti, G ;

Peracchia, G ;

Corti, A .

CANCER RESEARCH, 2006, 66 (02) :1234-1240

[14] Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of bcl-2 [J].

Blutt, SE ;

McDonnell, TJ ;

Polek, TC ;

Weigel, NL .

ENDOCRINOLOGY, 2000, 141 (01) :10-17

[15] Insulin-like growth factor binding protein-3 mediates 1α,25-dihydroxyvitamin D3 growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1 [J].

Boyle, BJ ;

Zhao, XY ;

Cohen, P ;

Feldman, D .

JOURNAL OF UROLOGY, 2001, 165 (04) :1319-1324

[16] The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression [J].

Caporali, A ;

Davalli, P ;

Astancolle, S ;

D'Arca, D ;

Brausi, M ;

Bettuzzi, S ;

Corti, A .

CARCINOGENESIS, 2004, 25 (11) :2217-2224

[17] Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention [J].

Chen, LW ;

Stacewicz-Sapuntzakis, M ;

Duncan, C ;

Sharifi, R ;

Ghosh, L ;

van Breemen, R ;

Ashton, D ;

Bowen, PE .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (24) :1872-1879

[18]

Cho SD, 2004, MOL CANCER THER, V3, P605

[19] A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach [J].

Choan, E ;

Segal, R ;

Jonker, D ;

Malone, S ;

Reaume, N ;

Eapen, L ;

Gallant, V .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2005, 23 (02) :108-113

[20] Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells [J].

Chung, LY ;

Cheung, TC ;

Kong, SK ;

Fung, KP ;

Choy, YM ;

Chen, ZY ;

Kwok, TT .

LIFE SCIENCES, 2001, 68 (10) :1207-1214

← 1 2 3 4 5 6 7 8 9 10 →